The human pathogen Staphylococcus aureus is isolated and characterized using traditional culture and sensitivity methodologies that are slow and offer limited information on the organism. In contrast, DNA microarray technology can provide detailed, clinically relevant information on the isolate by detecting the presence or absence of a large number of virulence-associated genes simultaneously in a single assay. We have developed and validated a novel, cost-effective multiwell microarray for the identification and characterization of Staphylococcus aureus. The array comprises 84 gene targets, including species-specific, antibiotic resistance, toxin, and other virulence-associated genes, and is capable of examining 13 different isolates simultaneously, together with a reference control strain. Analysis of S. aureus isolates whose complete genome sequences have been determined (Mu50, N315, MW2, MRSA252, MSSA476) demonstrated that the array can reliably detect the combination of genes known to be present in these isolates. Characterization of a further 43 S. aureus isolates by the microarray and pulsed-field gel electrophoresis has demonstrated the ability of the array to differentiate between isolates representative of a spectrum of S. aureus types, including methicillin-susceptible, methicillin-resistant, community-acquired, and vancomycin-resistant S. aureus, and to simultaneously detect clinically relevant virulence determinants.Staphylococcus aureus is a common human pathogen responsible for a plethora of infections, from superficial skin infections to life-threatening diseases such as endocarditis, sepsis, and pneumonia. Methicillin-resistant S. aureus (MRSA) is a major cause of morbidity and mortality in the hospital setting. The emerging threats of community-associated MRSA (CA-MRSA) and vancomycin-resistant S. aureus (VRSA) highlight the importance of rapid detection of such infections.Most diagnostic microbiology laboratories continue to identify S. aureus using traditional culture and susceptibility methods that are slow (48 to 72 h) and provide only limited information. Molecular assays based on PCR have been reported for the detection of MRSA (4,6,7,9,10,30), the identification of staphylococcal species (17,20,21), or the identification of specific virulence genes (5,11,14,15,18,19,22,24,26,33). DNA microarrays can identify, subtype, and detect acquired antibiotic resistance determinants simultaneously (1,23,32,35); however, their clinical value has been limited by a complicated methodology that is unsuitable for routine use in diagnostic microbiology laboratories.We have developed an oligonucleotide-based microarray (designated VirEp, for virulence and epidemiology microarray) incorporating 84 clinically relevant gene targets for the characterization and molecular typing of clinical isolates of S. aureus in an economical, multiwell format enabling 13 S. aureus isolates to be analyzed simultaneously.
MATERIALS AND METHODSBacterial isolates and culture conditions. The isolates used in this study (Table ...